Amplio Pharma AB
Methotrexate Forte – an innovation towards its clinical proof of concept
1. An immediate release pharmaceutical composition comprising (i) a therapeutic amount of methotrexate or any pharmaceutically acceptable salts thereof, (ii) a non-therapeutic amount of novobiocin or any pharmaceutically acceptable salts thereof, optionally in the association with one or more pharmaceutically acceptable excipient, carrier or diluent.
with dependent claims describing details on the formulation and its use in treatment of disease
Know more of this patent
Under evaluation at least till: 21st of February 2023